Factors correlated with the improvement of endothelial dysfunction during Abatacept therapy in patients with rheumatoid arthritis

References

• KremersHMCrowsonCSTherneauTMRogerVLGabrielSEHigh ten-year risk of cardiovascular disease in newly diagnosed rheumatoid arthritis patients: a population-based cohort studyArthritis Rheum20085882268227418668561
   PubMed Web of Science ®Google Scholar
• Aviña-ZubietaJAChoiHKSadatsafaviMElminanMEsdaileJMLacailleDRisk of cardiovascular mortality in patients with rheumatoid arthritis: a meta-analysis of observational studiesArthritis Rheum200859121690169719035419
   PubMed Web of Science ®Google Scholar
• SolomonDHGoodsonNJKatzJNPatterns of cardiovascular risk in rheumatoid arthritisAnn Rheum Dis200665121608161216793844
   PubMed Web of Science ®Google Scholar
• Maradit-KremersHNicolaPJCrowsonCSBallmanKVGabrielSECardiovascular death in rheumatoid arthritis: a population-based studyArthritis Rheum200552372273215751097
   PubMed Web of Science ®Google Scholar
• SolomonDHKarlsonEWRimmEBCardiovascular morbidity and mortality in women diagnosed with rheumatoid arthritisCirculation200310791303130712628952
   PubMed Web of Science ®Google Scholar
• del RincónIDWilliamsKSternMPFreemanGLEscalanteAHigh incidence of cardiovascular events in a rheumatoid arthritis cohort not explained by traditional cardiac risk factorsArthritis Rheum200144122737274511762933
   PubMed Web of Science ®Google Scholar
• WolfeFMichaudKThe risk of myocardial infarction and pharmacologic and nonpharmacologic myocardial infarction predictors in rheumatoid arthritis: a cohort and nested case-control analysisArthritis Rheum20085892612262118759273
   PubMed Web of Science ®Google Scholar
• Del RincónIWilliamsKSternMPFreemanGLO’LearyDHEscalanteAAssociation between carotid atherosclerosis and markers of inflammation in rheumatoid arthritis patients and healthy subjectsArthritis Rheum20034871833184012847676
   PubMed Web of Science ®Google Scholar
• GoodsonNJSymmonsDPScottDGBunnDLuntMSilmanAJBaseline levels of C-reactive protein and prediction of death from cardiovascular disease in patients with inflammatory polyarthritis: a ten-year followup study of a primary care-based inception cohortArthritis Rheum20055282293229916052597
   PubMed Web of Science ®Google Scholar
• Van DoornumSMcCollGWicksIPAccelerated atherosclerosis: an extraarticular feature of rheumatoid arthritis?Arthritis Rheum200246486287311953961
   PubMed Web of Science ®Google Scholar
• YangXChangYWeiWEndothelial dysfunction and inflammation: immunity in rheumatoid arthritisMediators Inflamm20162016681301627122657
   PubMed Web of Science ®Google Scholar
• VitaJAKeaneyJFJrEndothelial function: a barometer for cardiovascular risk?Circulation2002106664064212163419
   PubMed Web of Science ®Google Scholar
• Gonzalez-JuanateyCTestaAGarcia-CasteloAHLA-DRB1 status affects endothelial function in treated patients with rheumatoid arthritisAm J Med2003114864765212798452
   PubMed Web of Science ®Google Scholar
• Gonzalez-JuanateyCTestaAGarcia-CasteloAGarcia-PorruaCLlorcaJGonzalez-GayMAActive but transient improvement of endothelial function in rheumatoid arthritis patients undergoing long-term treatment with anti-tumor necrosis factor alpha antibodyArthritis Rheum200451344745015188332
   PubMed Web of Science ®Google Scholar
• MathieuSCoudercMGlaceBEffects of 6 months of abatacept treatment on aortic stiffness in patients with rheumatoid arthritisBiologics2013725926424324327
   PubMedGoogle Scholar
• SandooAKitasGDThe impact of abatacept treatment on the vasculature in patients with rheumatoid arthritisClin Exp Rheumatol201533458926121184
   PubMed Web of Science ®Google Scholar
• KerekesGSzekaneczZDérHEndothelial dysfunction and atherosclerosis in rheumatoid arthritis: a multiparametric analysis using imaging techniques and laboratory markers of inflammation and autoimmunityJ Rheumatol200835339840618203326
   PubMed Web of Science ®Google Scholar
• TotosonPMaguin-GatéKPratiCWendlingDDemougeotCMechanisms of endothelial dysfunction in rheumatoid arthritis: lessons from animal studiesArthritis Res Ther201416120224457026
   PubMed Web of Science ®Google Scholar
• HanssonGKHermanssonAThe immune system in atherosclerosisNat Immunol201112320421221321594
   PubMed Web of Science ®Google Scholar
• GotsmanISharpeAHLichtmanAHT-cell costimulation and coinhibition in atherosclerosisCirc Res2008103111220123119028921
   PubMed Web of Science ®Google Scholar
• EwingMMKarperJCAbdulST-cell co-stimulation by CD28-CD80/86 and its negative regulator CTLA-4 strongly influence accelerated atherosclerosis developmentInt J Cardiol201316831965197423351788
   PubMed Web of Science ®Google Scholar
• MitrokhinVNikitinABrovkinaOAssociation between interleukin-6/6R gene polymorphisms and coronary artery disease in Russian population: influence of interleukin-6/6R gene polymorphisms on inflammatory markersJ Inflamm Res20171015116029042807
   PubMed Web of Science ®Google Scholar
• MaHSunGWangWAssociation between Interleukin-6-572 C>G and -174 G>C polymorphisms and hypertension: a meta-analysis of case control studiesMedicine (Baltimore)2016952e241626765421
   PubMed Web of Science ®Google Scholar
• ZhangLLWangYQFuBZhaoSLKuiYAldehyde dehydrogenase 2 (ALDH2) polymorphism gene and coronary artery disease risk: a meta-analysisGenet Mol Res2015144185031851426782498
   PubMed Web of Science ®Google Scholar
• CutoloMPaolinoSPizzorniCEffects of combined treatments with CTLA4-IG (abatacept), dexamethasone and methotrexate on cultured human macrophagesClin Exp Rheumatol201634350050626940199
   PubMed Web of Science ®Google Scholar
• CutoloMSoldanoSContiniPIntracellular NF-kB-decrease and IKBα increase in human macrophages following CTLA4-Ig treatmentClin Exp Rheumatol201331694394624295474
   PubMed Web of Science ®Google Scholar
• KumeKAmanoKYamadaSHattaKOhtaHKuwabaNTocili-zumab monotherapy reduces arterial stiffness as effectively as etanercept or adalimumab monotherapy in rheumatoid arthritis: an open-label randomized controlled trialJ Rheumatol201138102169217121807781
   PubMed Web of Science ®Google Scholar
• ProtogerouADZampeliEFragiadakiKStamatelopoulosKPapamichaelCSfikakisPPA pilot study of endothelial dysfunction and aortic stiffness after interleukin-6 receptor inhibition in rheumatoid arthritisAtherosclerosis2011219273473621968316
   PubMed Web of Science ®Google Scholar
• KimSCSolomonDHRogersJRCardiovascular safety of Tocilizumab versus tumor necrosis factor inhibitors in patients with rheumatoid arthritis: a multi-database cohort studyArthritis Rheumatol20176961154116428245350
   PubMed Web of Science ®Google Scholar
• PopaCNeteaMGRadstakeTInfluence of anti-tumour necrosis factor therapy on cardiovascular risk factors in patients with active rheumatoid arthritisAnn Rheum Dis200564230330515231512
   PubMed Web of Science ®Google Scholar
• SidiropoulosPISiakkaPPagonidisKSustained improvement of vascular endothelial function during anti-TNFa treatment in rheumatoid arthritis patientsScand J Rheumatol200938161018991190
   PubMed Web of Science ®Google Scholar
• SpinelliFRPecaniACiciarelloFAssociation between antibodies to carbamylated proteins and subclinical atherosclerosis in rheumatoid arthritis patientsBMC Musculoskelet Disord20171821428545441
   PubMed Web of Science ®Google Scholar